Posdinemab is an investigational monoclonal antibody that targets the mid-domain of Alzheimer's disease-specific ...
The average life expectancy of people diagnosed with dementia ranges from 9 years at age 60 to 4.5 years at age 85 for women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback